Tag: pharmaceutical

1. The cost of research and development (R&D) for a company to develop their first FDA approved cancer medication is estimated to be $648.0 million, while revenue was substantially greater despite relatively short time on the market. 2. In-house preclinical development and first-in-class medications required greater research and development cost. Evidence...
1. The authors of this study found an association between market competition and generic drug prices. 2. Measuring market competition may help identify drugs requiring intervention to avoid increases in generic drug prices. Evidence Rating Level: 2 (Good) Study Rundown: In the United States, generic drug use has increased over the past...
1. In this 2015 US-based, retrospective study, half of physicians received payments from industry. 2. Surgeons had the highest likelihood of receiving payments with the greatest value of receipts when compared to medical specialists, interventionalists, and primary care physicians. Evidence Rating Level: 2 (Good) Study Rundown: Ample evidence has shown that even...
1. In this cross-sectional analysis of Medicare data, physicians who received a sponsored meal from pharmaceutical industries were more likely to prescribe the promoted brand-name medication. 2. While the absolute increase in prescribing the promoted-drug was relatively small, the impact on prescribing patterns was additive with greater number of meals...
Image: PD 1. Over the past decade, 63% of panels proposing changes in disease definitions elected to widen the definition, potentially fueling over-diagnosis. 2. In most of these panels, panelists are healthcare professionals with ties to multiple pharmaceutical companies. Evidence Rating Level: 2 (Good) Study Rundown: Over the past decade, the public and...
Image: PD 1. Among Medicare beneficiaries studied, 7.5% reported a reduction in dose or delay in filling medications, and 8.2% reported not filling a medication at all, due to cost concerns. 2. Disabled Medicare beneficiaries with severe cost-related medication nonadherence had a 1.53 greater odds of any Emergency Department (ED) visit within the...